Ignite Creation Date:
2025-12-25 @ 4:53 AM
Ignite Modification Date:
2026-01-18 @ 9:28 AM
Study NCT ID:
NCT06287918
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-11-29
First Post:
2024-02-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A First-in-human Study of 3HP-2827 in Patients With Unresectable or Metastatic Solid Tumors With FGFR2 Alterations
Sponsor:
3H (Suzhou) Pharmaceuticals Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
3HP-2827-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None